Publication | Closed Access

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

MedicineClinical TrialsMaintenance TherapyImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentGefitinib Versus PlaceboOncologyRadiation OncologyLung CancerPhase 3Health Sciences